Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
Kgeiersbach (talk | contribs) |
||
| Line 3,624: | Line 3,624: | ||
|2021 template added | |2021 template added | ||
|- | |- | ||
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde | |Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach | ||
|8/11/2023 | |8/11/2023 | ||
|11/11/2023 | |11/11/2023 | ||
| | |PENDING | ||
| | | | ||
|Hui Chen | |Hui Chen | ||
| Line 3,905: | Line 3,905: | ||
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach | |BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach | ||
|12/6/2023 | |12/6/2023 | ||
|3/ | |3/6/2024 | ||
| | | | ||
| | | | ||
| Line 3,923: | Line 3,923: | ||
|Ataxia-Telangiectasia||Disease||Evin Gulbahce | |Ataxia-Telangiectasia||Disease||Evin Gulbahce | ||
|8/11/2023 | |8/11/2023 | ||
| | | | ||
| | | | ||
| | | | ||
| Line 3,957: | Line 3,957: | ||
| | | | ||
|- | |- | ||
|PALB2-Associated Cancers||Disease||Katherine Geiersbach | |PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach | ||
| | |12/8/2023 | ||
| | |3/8/2024 | ||
| | | | ||
| | | | ||